Abbott Laboratories Current Ratio 2006-2019 | ABT

Current and historical current ratio for Abbott Laboratories (ABT) from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Abbott Laboratories current ratio for the three months ending June 30, 2019 was 1.68.
Abbott Laboratories Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $15.20B $9.06B 1.68
2019-03-31 $14.41B $9.11B 1.58
2018-12-31 $14.63B $9.01B 1.62
2018-09-30 $18.20B $12.78B 1.42
2018-06-30 $14.12B $8.95B 1.58
2018-03-31 $14.96B $9.01B 1.66
2017-12-31 $20.15B $8.91B 2.26
2017-09-30 $21.38B $7.94B 2.69
2017-06-30 $19.98B $6.80B 2.94
2017-03-31 $19.33B $6.65B 2.91
2016-12-31 $26.78B $6.66B 4.02
2016-09-30 $12.98B $8.32B 1.56
2016-06-30 $12.99B $8.67B 1.50
2016-03-31 $12.41B $8.39B 1.48
2015-12-31 $14.16B $9.19B 1.54
2015-09-30 $15.89B $8.76B 1.82
2015-06-30 $21.13B $9.19B 2.30
2015-03-31 $19.99B $9.21B 2.17
2014-12-31 $13.56B $10.47B 1.30
2014-09-30 $16.46B $10.82B 1.52
2014-06-30 $18.26B $9.85B 1.85
2014-03-31 $17.93B $10.19B 1.76
2013-12-31 $19.25B $9.51B 2.03
2013-09-30 $19.75B $11.33B 1.74
2013-06-30 $19.83B $10.92B 1.82
2013-03-31 $19.10B $10.41B 1.84
2012-12-31 $31.32B $13.28B 2.36
2012-09-30 $27.26B $16.29B 1.67
2012-06-30 $26.26B $17.12B 1.53
2012-03-31 $25.60B $16.79B 1.53
2011-12-31 $23.77B $15.48B 1.54
2011-09-30 $23.09B $15.41B 1.50
2011-06-30 $24.13B $15.84B 1.52
2011-03-31 $23.65B $17.23B 1.37
2010-12-31 $22.32B $17.26B 1.29
2010-09-30 $19.45B $15.58B 1.25
2010-06-30 $19.92B $14.69B 1.36
2010-03-31 $17.69B $15.18B 1.17
2009-12-31 $23.31B $13.05B 1.79
2009-09-30 $21.42B $12.53B 1.71
2009-06-30 $19.63B $12.04B 1.63
2009-03-31 $18.01B $11.77B 1.53
2008-12-31 $17.04B $11.59B 1.47
2008-09-30 $15.23B $9.56B 1.59
2008-06-30 $16.96B $12.02B 1.41
2008-03-31 $15.11B $10.77B 1.40
2007-12-31 $14.04B $9.10B 1.54
2007-09-30 $12.84B $12.28B 1.05
2007-06-30 $12.34B $12.01B 1.03
2007-03-31 $11.50B $12.31B 0.94
2006-12-31 $11.28B $11.95B 0.94
2006-09-30 $10.07B $7.43B 1.36
2006-06-30 $9.90B $7.69B 1.29
2006-03-31 $10.61B $7.16B 1.48
2005-12-31 $11.39B $7.42B 1.54
2005-09-30 $10.99B $8.76B 1.26
2005-06-30 $9.66B $6.08B 1.59
2005-03-31 $10.35B $7.37B 1.41
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $148.939B $30.578B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $147.141B 20.65
Stryker (SYK) United States $81.622B 28.23
Boston Scientific (BSX) United States $58.240B 28.25
Baxter (BAX) United States $44.383B 26.91
EssilorLuxottica Societe Anonyme (ESLOY) France $31.497B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.496B 18.24
Lonza Group Ag (LZAGY) Switzerland $25.271B 0.00
Coloplast (CLPBY) Denmark $24.948B 39.83
Terumo (TRUMY) Japan $22.330B 25.68
Smith & Nephew SNATS (SNN) United Kingdom $20.407B 0.00
ResMed (RMD) United States $18.992B 36.22
Sunny Optical Technology (SNPTF) China $16.672B 0.00
Bio-Rad Laboratories (BIO) United States $9.967B 53.43
Canopy Growth (CGC) Canada $9.552B 0.00
Insulet (PODD) United States $8.633B 511.57
Perrigo (PRGO) Ireland $7.614B 14.02
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $7.024B 20.94
Haemonetics (HAE) United States $6.359B 47.99
Aurora Cannabis (ACB) Canada $6.071B 0.00
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
GW Pharmaceuticals (GWPH) United Kingdom $4.356B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $4.116B 68.33
NuVasive (NUVA) United States $3.380B 26.95
ICU Medical (ICUI) United States $3.364B 21.82
Hutchison China MediTech (HCM) China $2.903B 0.00
Quidel (QDEL) United States $2.783B 27.64
National Vision Holdings (EYE) United States $2.407B 51.95
Agios Pharmaceuticals (AGIO) United States $2.217B 0.00
Cardiovascular Systems (CSII) United States $1.794B 0.00
Aphria (APHA) $1.687B 0.00
VAREX IMAGING (VREX) United States $1.129B 26.01
AtriCure (ATRC) United States $0.989B 0.00
Lantheus Holdings (LNTH) United States $0.956B 25.12
Omeros (OMER) United States $0.915B 0.00
Phibro Animal Health (PAHC) United States $0.866B 14.08
Eagle Pharmaceuticals (EGRX) United States $0.787B 20.07
NanoString Technologies (NSTG) United States $0.774B 0.00
PetIQ (PETQ) United States $0.751B 17.74
Cerus (CERS) United States $0.747B 0.00
LeMaitre Vascular (LMAT) United States $0.705B 41.80
Quanterix (QTRX) United States $0.654B 0.00
MacroGenics (MGNX) United States $0.640B 0.00
Surmodics (SRDX) United States $0.632B 120.08
TG Therapeutics (TGTX) United States $0.614B 0.00
OraSure Technologies (OSUR) United States $0.468B 21.69
Meridian Bioscience (VIVO) United States $0.422B 13.16
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.409B 0.00
Owens & Minor (OMI) United States $0.394B 11.81
BioLife Solutions (BLFS) United States $0.385B 126.69
Utah Medical Products (UTMD) United States $0.369B 27.00
United Health Products (UEEC) United States $0.325B 0.00
Zynex (ZYXI) United States $0.292B 31.03
Bovie Medical (APYX) United States $0.256B 0.00
Rockwell Medical (RMTI) United States $0.197B 0.00
Cytosorbents (CTSO) United States $0.177B 0.00
Vapotherm (VAPO) United States $0.159B 0.00
Fonar (FONR) United States $0.157B 11.17
Chimerix (CMRX) United States $0.135B 0.00
Female Health (VERU) United States $0.124B 0.00
Chembio Diagnostics (CEMI) United States $0.118B 0.00
InfuSystems Holdings (INFU) United States $0.106B 0.00
United-Guardian (UG) United States $0.088B 20.72
MRI Interventions (MRIC) United States $0.065B 0.00
Nephros (NEPH) United States $0.058B 0.00
Surface Oncology (SURF) United States $0.058B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Trinity Biotech (TRIB) Ireland $0.031B 0.00
Senestech (SNES) United States $0.025B 0.00
Myomo (MYO) United States $0.014B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
GUARDION HEALTH (GHSI) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00